GlycoErase™ B3GLCT Knockout CHO-K1 Cell Line (CAT#: GLJF-0425-JF115)

Description	The B3GLCT knockout (CHO-K1) cell line, without B3GLCT beta 3-glucosyltransferase, may disrupt O-linked glycosylation of TSRs in CHO cells and potentially contribute to Peters-plus syndrome-related studies, B3GLCT transfers glucose to O-linked fucosylglycans on thrombospondin type-1 repeats, relevant to O-glycan modification of TSR-containing therapeutic proteins in CHO.
Product Type	KO Cell Lines
Species	Hamster
Cell Morphology	Epithelial, adherent
Passage Ratio	1:3~1:5
Cell Line	CHO-K1
Lineage	Chinese hamster ovary

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	PCR, Sanger Sequencing
Culture Medium	FBS & Penicillin/Streptomycin & Proline & RPMI
Application	Functional assay
Size	2 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	B3GLCT
Full Name	Beta 3-glucosyltransferase
Alternative Name	B3Glc-T, B3GTL, B3GALTL
Location	13q12.3
Gene ID	145173
Summary	Beta-1,3-glucosyltransferase that transfers glucose to O-linked fucosylglycans on thrombospondin type-1 repeats; defects cause Peters-plus syndrome.